Although IL-4 deficiency alone does not exacerbate insulitis severity in NOD mice, experimental strategies that enhance IL-4 expression, including systemic or local administration, or genetic engineering of β-cells and dendritic cells, can delay diabetes onset and reduce disease incidence. This evidence concerns the gene IL4 and diabetes mellitus.